Jaguar Health Inc (NASDAQ: JAGX) kicked off on Friday, down -5.19% from the previous trading day, before settling in for the closing price of $1.35. Over the past 52 weeks, JAGX has traded in a range of $1.26-$39.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 39.38% over the past five years. While this was happening, its average annual earnings per share was recorded 99.36%. With a float of $4.18 million, this company’s outstanding shares have now reached $4.79 million.
Let’s look at the performance matrix of the company that is accounted for 49 employees.
Jaguar Health Inc (JAGX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Jaguar Health Inc is 12.63%, while institutional ownership is 1.99%.
Jaguar Health Inc (JAGX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 3/31/2024, the organization reported -540 earnings per share (EPS), lower than consensus estimate (set at -337.5) by -202.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 99.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to 86.10% growth over the previous five years of trading.
Jaguar Health Inc (NASDAQ: JAGX) Trading Performance Indicators
Take a look at Jaguar Health Inc’s (JAGX) current performance indicators. Last quarter, stock had a quick ratio of 1.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -74.86, a number that is poised to hit -1.20 in the next quarter and is forecasted to reach -2.51 in one year’s time.
Technical Analysis of Jaguar Health Inc (JAGX)
Jaguar Health Inc (NASDAQ: JAGX) saw its 5-day average volume 4.33 million, a positive change from its year-to-date volume of 0.95 million. As of the previous 9 days, the stock’s Stochastic %D was 2.23%. Additionally, its Average True Range was 0.54.
During the past 100 days, Jaguar Health Inc’s (JAGX) raw stochastic average was set at 0.15%, which indicates a significant decrease from 0.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 364.92% in the past 14 days, which was higher than the 232.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.7758, while its 200-day Moving Average is $9.6098. Nevertheless, the first resistance level for the watch stands at $1.3633 in the near term. At $1.4467, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5033. If the price goes on to break the first support level at $1.2233, it is likely to go to the next support level at $1.1667. Assuming the price breaks the second support level, the third support level stands at $1.0833.
Jaguar Health Inc (NASDAQ: JAGX) Key Stats
The company with the Market Capitalisation of 6.13 million has total of 4,905K Shares Outstanding. Its annual sales at the moment are 9,760 K in contrast with the sum of -41,300 K annual income. Company’s last quarter sales were recorded 2,350 K and last quarter income was -9,230 K.
